Concepedia

Habib Hamidi

HH

Statistics

Publications

30

Citations

2.8K

H-Index

23

Active since

2002

Affiliations

University of California, Los Angeles(Current)

Memorial Sloan Kettering Cancer Center

Mayo Clinic in Florida

The University of Texas MD Anderson Cancer Center

Institut Gustave Roussy

Habib Hamidi is an author at University of California, Los Angeles specializing in oncology, medicine, and molecular oncology.

Publications per year

2002–2025

30

Publications

30

Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade

Robert J. Motzer, Romain Banchereau, Habib Hamidi et al. · Cancer Cell · 2020 · 561 citations · Full text

Medicine, Cancer Biology, Oncology +16

Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer

Gottfried E. Konecny, Chen Wang, Habib Hamidi et al. · JNCI Journal of the National Cancer Institute · 2014 · 408 citations · Full text

Medicine, Cancer Biology, Oncology +17

MS-27-275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors.

Jerry J. Jaboin, Jason R. Wild, Habib Hamidi et al. · PubMed · 2002 · 229 citations

Medicine, Oncology, Pharmacology +12

CD8+ T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy

Mahrukh Huseni, Lifen Wang, Joanna E. Klementowicz et al. · Cell Reports Medicine · 2023 · 183 citations · Full text

Life Sciences, Immunology, Oncology +17

Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

Robert J. Motzer, Thomas Powles, Michael B. Atkins et al. · JAMA Oncology · 2021 · 163 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 30